525 related articles for article (PubMed ID: 23918359)
21. Gamisasangja-tang suppresses pruritus and atopic skin inflammation in the NC/Nga murine model of atopic dermatitis.
Park BK; Park YC; Jung IC; Kim SH; Choi JJ; Do M; Kim SY; Jin M
J Ethnopharmacol; 2015 May; 165():54-60. PubMed ID: 25721805
[TBL] [Abstract][Full Text] [Related]
22. IL-17A-Producing Innate Lymphoid Cells Promote Skin Inflammation by Inducing IL-33-Driven Type 2 Immune Responses.
Kim MH; Jin SP; Jang S; Choi JY; Chung DH; Lee DH; Kim KH; Kim HY
J Invest Dermatol; 2020 Apr; 140(4):827-837.e9. PubMed ID: 31628929
[TBL] [Abstract][Full Text] [Related]
23. Topical application of an ethanol extract prepared from Illicium verum suppresses atopic dermatitis in NC/Nga mice.
Sung YY; Yang WK; Lee AY; Kim DS; Nho KJ; Kim YS; Kim HK
J Ethnopharmacol; 2012 Oct; 144(1):151-9. PubMed ID: 22971899
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.
Rebane A; Runnel T; Aab A; Maslovskaja J; Rückert B; Zimmermann M; Plaas M; Kärner J; Treis A; Pihlap M; Haljasorg U; Hermann H; Nagy N; Kemeny L; Erm T; Kingo K; Li M; Boldin MP; Akdis CA
J Allergy Clin Immunol; 2014 Oct; 134(4):836-847.e11. PubMed ID: 24996260
[TBL] [Abstract][Full Text] [Related]
25. IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.
Floudas A; Saunders SP; Moran T; Schwartz C; Hams E; Fitzgerald DC; Johnston JA; Ogg GS; McKenzie AN; Walsh PT; Fallon PG
J Immunol; 2017 Jul; 199(2):707-717. PubMed ID: 28615416
[TBL] [Abstract][Full Text] [Related]
26. Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model.
Chen L; Martinez O; Overbergh L; Mathieu C; Prabhakar BS; Chan LS
Clin Exp Immunol; 2004 Dec; 138(3):375-87. PubMed ID: 15544612
[TBL] [Abstract][Full Text] [Related]
27. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.
Lefrançais E; Duval A; Mirey E; Roga S; Espinosa E; Cayrol C; Girard JP
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15502-7. PubMed ID: 25313073
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells.
Roediger B; Kyle R; Yip KH; Sumaria N; Guy TV; Kim BS; Mitchell AJ; Tay SS; Jain R; Forbes-Blom E; Chen X; Tong PL; Bolton HA; Artis D; Paul WE; Fazekas de St Groth B; Grimbaldeston MA; Le Gros G; Weninger W
Nat Immunol; 2013 Jun; 14(6):564-73. PubMed ID: 23603794
[TBL] [Abstract][Full Text] [Related]
29. Eosinophils increase neuron branching in human and murine skin and in vitro.
Foster EL; Simpson EL; Fredrikson LJ; Lee JJ; Lee NA; Fryer AD; Jacoby DB
PLoS One; 2011; 6(7):e22029. PubMed ID: 21811556
[TBL] [Abstract][Full Text] [Related]
30. RORα-expressing T regulatory cells restrain allergic skin inflammation.
Malhotra N; Leyva-Castillo JM; Jadhav U; Barreiro O; Kam C; O'Neill NK; Meylan F; Chambon P; von Andrian UH; Siegel RM; Wang EC; Shivdasani R; Geha RS
Sci Immunol; 2018 Mar; 3(21):. PubMed ID: 29500225
[TBL] [Abstract][Full Text] [Related]
31. The involvement of eosinophils in the patch test reaction to aeroallergens in atopic dermatitis: its relevance for the pathogenesis of atopic dermatitis.
Bruijnzeel PL; Kuijper PH; Kapp A; Warringa RA; Betz S; Bruijnzeel-Koomen CA
Clin Exp Allergy; 1993 Feb; 23(2):97-109. PubMed ID: 8448687
[TBL] [Abstract][Full Text] [Related]
32. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
Park CW; Lee BH; Han HJ; Lee CH; Ahn HK
Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of RANTES, CCR3 and CCR5 in the lesional skin of patients with atopic eczema.
Kato Y; Pawankar R; Kimura Y; Kawana S
Int Arch Allergy Immunol; 2006; 139(3):245-57. PubMed ID: 16449815
[TBL] [Abstract][Full Text] [Related]
34. T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.
Matsuki A; Takatori H; Makita S; Yokota M; Tamachi T; Suto A; Suzuki K; Hirose K; Nakajima H
J Allergy Clin Immunol; 2017 Apr; 139(4):1355-1367.e6. PubMed ID: 27670243
[TBL] [Abstract][Full Text] [Related]
35. New mechanism underlying IL-31-induced atopic dermatitis.
Meng J; Moriyama M; Feld M; Buddenkotte J; Buhl T; Szöllösi A; Zhang J; Miller P; Ghetti A; Fischer M; Reeh PW; Shan C; Wang J; Steinhoff M
J Allergy Clin Immunol; 2018 May; 141(5):1677-1689.e8. PubMed ID: 29427643
[TBL] [Abstract][Full Text] [Related]
36. Chemokine-like factor 1 (CLFK1) is over-expressed in patients with atopic dermatitis.
Yang GY; Chen X; Sun YC; Ma CL; Qian G
Int J Biol Sci; 2013; 9(8):759-65. PubMed ID: 23983609
[TBL] [Abstract][Full Text] [Related]
37. Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway.
Lou H; Lu J; Choi EB; Oh MH; Jeong M; Barmettler S; Zhu Z; Zheng T
J Immunol; 2017 Apr; 198(7):2543-2555. PubMed ID: 28228560
[TBL] [Abstract][Full Text] [Related]
38. The potential role of allergen-specific sublingual immunotherapy in atopic dermatitis.
Mastrandrea F
Am J Clin Dermatol; 2004; 5(5):281-94. PubMed ID: 15554729
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E
Sawada Y; Honda T; Nakamizo S; Nakajima S; Nonomura Y; Otsuka A; Egawa G; Yoshimoto T; Nakamura M; Narumiya S; Kabashima K
J Allergy Clin Immunol; 2019 Nov; 144(5):1265-1273.e9. PubMed ID: 31301371
[TBL] [Abstract][Full Text] [Related]
40. Natural killer T cells expressing IFN-gamma and IL-4 in lesional skin of atopic eczema.
Simon D; Kozlowski E; Simon H
Allergy; 2009 Nov; 64(11):1681-4. PubMed ID: 19735490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
